20 Mg Octreotide Long Acting Rekease Injection

Name: 20 Mg Octreotide Long Acting Rekease Injection
Brand: NEETCO BIOPHARMA
Price: 12000 INR
Availability: InStock

Price 12000 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

20 Mg Octreotide Long Acting Rekease Injection Specification

Dosage Form
Long Acting Release Injection

Salt Composition
Octreotide Acetate 20 mg

Indication
Used in treatment of acromegaly, carcinoid tumors, vasoactive intestinal peptide tumors, and other related conditions

Enzyme Types
Not Applicable (Peptide medication, not enzyme)

Feature
Long-acting, sustained release for once-monthly dosing

Ingredients
Octreotide Acetate, Polymer matrix, Excipients

Application
Parenteral administration for therapeutic use

Physical Color/Texture
White to off-white powder or lyophilized cake in vial

Fermentation Smell
Odorless

Enzymatic Activity
None (Peptide analog, not enzyme)

Storage Instructions
Store at 2C to 8C (Refrigerated). Do not freeze.

Shelf Life
24 months from the date of manufacture

Prescribing Information
For use under medical supervision only

Manufacturing Standard
cGMP compliant

Available Strengths
20 mg (other strengths may be available)

Route of Administration
Intramuscular injection

Packaging Type
Vial with solvent for reconstitution

Reconstitution Instructions
To be reconstituted with provided solvent prior to injection

Brand Name
Varies by manufacturer

Container Material
Glass Vial

About 20 Mg Octreotide Long Acting Rekease Injection

Procure the top-tier 20 Mg Octreotide Long Acting Release Injection, a triumphant and flawless new release designed for sustained therapeutic efficacy. Crafted under stringent cGMP-compliant manufacturing, this ineffable peptide medication is presented as a white to off-white lyophilized powder for parenteral administration. Delivered in a glass vial with solvent for precise reconstitution, its long-acting formulation ensures once-monthly dosing for the treatment of acromegaly, carcinoid, and VIPomas. Available from distributors, exporters, and suppliers across India, it offers robust performance with impeccable safety and storage credentials.

Triumphant Competitive Edge & Usage Excellence

The 20 Mg Octreotide Long Acting Release Injection offers primary competitive advantages including prolonged action, superior quality, and dependable supply. Its once-monthly dosing provides a convenient, flawless patient experience, reducing hospital visits. With cGMP compliance, efficacy in diverse clinical indications, and reliable reconstitution process for intramuscular injection, it is suitable for both hospital and clinic-based practitioners seeking sustained peptide therapy for their patients.

Export Capacity, Valuation, and Market Adaptability

Our supply ability caters to both expansive export markets and robust domestic demand. Flexible payment terms support secure trade and distributor partnerships. Sample policy enables valuation and assessment prior to large orders. The product's shelf life, packaging integrity, and compliance with quality standards position it as a leading choice for international traders, exporters, and suppliers targeting various healthcare segments.

FAQ's of 20 Mg Octreotide Long Acting Rekease Injection:

Q: How should the 20 Mg Octreotide Long Acting Release Injection be reconstituted?

A: This injection should be reconstituted only with the provided solvent. Follow the package instructions carefully before administering an intramuscular injection. Always use under medical supervision.

Q: What are the primary clinical indications for this medication?

A: This injection is primarily used to treat acromegaly, carcinoid tumors, and vasoactive intestinal peptide tumors, as well as other related conditions, offering sustained therapeutic benefits with each dose.

Q: When should this injection be administered?

A: Once reconstituted, the injection is typically administered as a once-monthly intramuscular dose, as directed by a healthcare professional according to patient needs.

Q: Where should the product be stored to maintain efficacy?

A: Store the unopened vial and solvent at 2C to 8C in a refrigerator. Do not freeze. Proper storage ensures medication potency and safety until the expiration date.

Q: What are the key competitive advantages of this injection?

A: The long-acting, sustained release formulation allows for monthly dosing, enhancing patient convenience and compliance, while its cGMP-compliant manufacturing ensures consistent quality and performance.

Q: How can distributors or healthcare providers procure this product?

A: Suppliers and distributors in India, as well as export markets, can obtain this injection through authorized channels, supported by flexible payment and sample evaluation policies for bulk procurement.

Tell us about your requirement